Showing results (51-60 of 253) with videos related to

Sort By:
Pageof 26
American Journal of Hematology|December 30, 2025
Extramedullary Disease-Achilles Heel in Myeloma?Shaji Kumar, Joshua Richter, Saad Z Usmani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2013
Molecular chaperone gp96 is a novel therapeutic target of multiple myelomaYunpeng Hua, Shai White-Gilbertson, Joshua Kellner, et al.
Blood Cancer Journal|December 18, 2023
Addressing the disparities: the approach to the African American patient with multiple myelomaManisha Bhutani, Brandon J Blue, Craig Cole, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Pre-Diagnosis Dietary Patterns and Risk of Multiple Myeloma in the NIH-AARP Diet and Health StudyFrancesca Castro, Richa Parikh, Jelyn C Eustaquio, et al.
Blood Advances|May 10, 2023
Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR studySaad Z Usmani, Hang Quach, Maria-Victoria Mateos, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 14, 2025
Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma Treated With Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: An Analysis of Patient-Reported Outcomes From the Phase 3 CANDOR TrialKatja Weisel, Maria-Victoria Mateos, Ola Landgren, et al.
Advances in Therapy|March 18, 2024
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level DataBrian G M Durie, Shaji K Kumar, Eric M Ammann, et al.
Blood Cancer Journal|November 29, 2023
Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survivalAnish K Simhal, Kylee H Maclachlan, Rena Elkin, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
High WEE1 expression is independently linked to poor survival in multiple myelomaAnish K Simhal, Ross Firestone, Jung Hun Oh, et al.
Frontiers in Oncology|February 25, 2022
Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted TreatmentClaudio Cerchione, Saad Z Usmani, A Keith Stewart, et al.
Pageof 26